Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // September 26th, 2007 // 7:29 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Lilly names Lauren Marangell as a Distinguished Scholar;
Cardinal Health named ceo R. Kerry Clark as chairman;
Shire appointed Sylvie Gregoire as prez, human genetic therapies biz;
Cell Therapeutics adds Richard Love to its board;
MacroGenics named Jeff Buchalter as chairman;
Stiefel Labs appointed Lodewijk de Vink, to its board;
Keryx Biopharmaceuticals named Mike Tarnok to its board;
Gen-Probe named John Martin to its board;
CG Therapeutics appointed Chris Henney as chairman;
United BioSource named Oto Markovic as regional mgr of its Prague office;
Nile Therapeutics named Daron Evans as cfo and Jennifer Hodge vp of development.
Hat tip to Pharmaceutical Executive